financetom
Business
financetom
/
Business
/
QUOTES-Reactions to Trump demanding Intel CEO's resignation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
QUOTES-Reactions to Trump demanding Intel CEO's resignation
Aug 7, 2025 8:10 AM

Aug 7 (Reuters) - U.S. President Donald Trump has

demanded the immediate resignation of Intel ( INTC ) CEO Lip-Bu

Tan over concerns of his extensive investments in Chinese firms,

just months after he assumed leadership of the struggling

chipmaker.

Tan has invested in hundreds of Chinese technology firms,

including at least eight with links to the People's Liberation

Army, Reuters reported in April.

On Wednesday, Reuters exclusively reported that Republican

Senator Tom Cotton questioned Tan's ties to Chinese firms and a

recent criminal case involving his former company Cadence Design ( CDNS )

.

Some analysts and investors said Tan's deep knowledge of the

Chinese semiconductor landscape is a strategic asset. Others see

the political pressure as a sign of growing uncertainty around

Intel ( INTC ).

Here are some key quotes.

ANSHEL SAG, PRINCIPAL ANALYST AT MOOR INSIGHTS & STRATEGY

"I believe that POTUS shouldn't be calling for any CEO to be

stepping down, especially not one who just took the job this

year. I think this all boils down to Lip-Bu's past involvement

and investment in Chinese semiconductors, which is also what

makes him so valuable as CEO."

"He's more aware than most people on earth of China's

capabilities and should be an asset to the U.S. and Intel ( INTC )."

DAVID WAGNER, HEAD OF EQUITY AND PORTFOLIO MANAGER AT APTUS

CAPITAL ADVISORS, AN INTEL SHAREHOLDER

"While I can understand that many investors likely believe

that President Trump has his hand in too many cookie jars, it's

just another signal that he's very serious about trying to bring

business back to the U.S. He has momentum from the Apple deal

and now hoping that a few more businesses fall into place."

RYUTA MAKINO, RESEARCH ANALYST AT GABELLI FUNDS, AN INTEL

INVESTOR

"I think Trump is mostly attacking Lip-Bu because he wanted

to stop the manufacturing business if Intel ( INTC ) 14A doesn't work out

with external customers. More speculation whether Trump is

making some deals with TSMC to do something with Intel ( INTC ). I think

it's very much a political move."

BLAKE ANDERSON, ASSOCIATE PORTFOLIO MANAGER AT CARSON GROUP

"Investors remaining focused on issues like these hint that

the company's manufacturing turnaround, and long-term viability,

may be dependent on factors external to the company and thus

increase long-term uncertainty."

SHIRAZ AHMED, FOUNDER AND CEO AT SARTORIAL WEALTH

"It's not surprising. I mean we're seeing the administration

step in and point fingers at private or corporate CEOs. It's not

the first time he's done it, it's likely not the last time he'll

do it."

PHIL BLANCATO, CEO OF LADENBURG THALMANN ASSET MANAGEMENT

"It would be setting a very unfortunate precedent. You don't

want American presidents dictating who runs companies, but

certainly his opinion has merit and weight. The board of Intel ( INTC )

will have to determine if that's something they would consider

in their evaluation."

"But this CEO is fairly new. So on one hand, I don't think

the U.S. president has the ability to do that. I'm not sure that

that's a good idea for any political official."

"But certainly, when you look at where the company stands

today, it hasn't benefited greatly over the last few years. And

I think it's more than just a CEO issue here. It's the company's

need for real, radical change."

(Reporting by Akash Sriram, Kritika Lamba, Twesha Dixit and

Johann M Cherian in Bengaluru; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
AbbVie's Rinvoq shows superiority to Regeneron's Dupixent in study
Apr 25, 2024
April 25 (Reuters) - AbbVie ( ABBV ) said on Thursday its drug, Rinvoq, for treating a type of inflammatory skin condition showed superior efficacy to Regeneron Pharmaceuticals ( REGN ) and Sanofi's Dupixent in a late-stage head-to-head study. ...
A. O. Smith posts quarterly profit beat on resilient water heater demand
A. O. Smith posts quarterly profit beat on resilient water heater demand
Apr 25, 2024
April 25 (Reuters) - Water heater maker A. O. Smith ( AOS ) reported a better-than-expected first-quarter profit on Thursday, aided by price hikes and resilient demand for its water heaters and treatment products in North America. The Milwaukee, Wisconsin-based company has also benefited from growing demand for its energy-efficient boilers as commercial buildings look to improve their carbon footprints....
Teck Resources Q1 Headline Results as Expected, Copper Portfolio Still
Teck Resources Q1 Headline Results as Expected, Copper Portfolio Still "Attractive Target," National Bank Says
Apr 25, 2024
08:20 AM EDT, 04/25/2024 (MT Newswires) -- National Bank noted that Teck Resources (TECK-B.TO, TECK-A.TO) before market open reported Q1 2024 ebitda headline results in line with consensus, but with EPS below National's estimates owing to the bank's treatment of interest in advances from Sumitomo for QB2 -- which otherwise would have been in line. National noted that despite lower...
Airbus in talks on China jet order ahead of Xi visit, sources say
Airbus in talks on China jet order ahead of Xi visit, sources say
Apr 25, 2024
PARIS/BEIJING, April 25 (Reuters) - Airbus is in talks with China over a potentially major aircraft order ahead of a visit to France by Chinese President Xi Jinping in May, two people familiar with the matter said. One of the people said the package could involve hundreds of jets, but the other cautioned talks are at a preliminary stage. Airbus...
Copyright 2023-2026 - www.financetom.com All Rights Reserved